Medication-info.com Search Menu

Podofilox: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
5 mg/mL
Active ingredient:

Patient information: uses, side effects, how to take - Podofilox

HOW TO USE PODOFILOX TOPICAL SOLUTION

Follow these and your doctor's instructions carefully. Apply Podofilox Topical Solution only on the warts pointed out by your doctor. Do not use it on any other warts on or inside your body, or for any other skin growth.

  1. 1. Open the bottle and put it on a flat surface. Hold the bottle and dip the applicator tip into the liquid. Touch the applicator tip against the inside edge of the bottle so the applicator is wet with no liquid dripping. Make sure to close the bottle tightly after use.
APPLY PODOFILOX TOPICAL SOLUTION ONLY WHERE YOUR DOCTOR HAS INSTRUCTED YOU
  1. 2. Apply Podofilox Topical Solution to the wart. Do not get it on normal skin. If a wart is in a skin fold, spread the skin apart so you can reach the wart. A hand mirror can help sometimes. Let Podofilox Topical Solution dry before letting the skin folds return to their normal position. Wash your hands well with soap and water after you use Podofilox Topical Solution.
  2. 3. Apply Podofilox Topical Solution once in the morning and once in the evening for three days in a row. Then stop applying Podofilox Topical Solution and wait four days. Using Podofilox Topical Solution like this is called a treatment week.There is no need to wash Podofilox Topical Solution off the wart area.
DO NOT APPLY PODOFILOX TOPICAL SOLUTION MORE THAN TWICE EACH DAY OR FOR MORE THAN THREE DAYS IN A ROW. USING PODOFILOX TOPICAL SOLUTION MORE OFTEN WILL NOT MAKE IT WORK BETTER BUT MAY INCREASE SIDE EFFECTS
  1. 4. If the warts do not go away, repeat the Podofilox Topical Solution treatment for another week. You can use Podofilox Topical Solution up to four treatment weeks (REMEMBER: a treatment week is twice a day for three days, then four days with no treatment). Your doctor may ask you to come back for a check-up visit during treatment. If the warts have not gone away after four treatment weeks, stop applying Podofilox Topical Solution and contact your doctor.
IF THE AREA YOU ARE PUTTING PODOFILOX TOPICAL SOLUTION ON IS BLEEDING OR SWOLLEN, OR IF THERE IS EXCESSIVE PAIN, BURNING OR ITCHING, STOP APPLYING PODOFILOX TOPICAL SOLUTION AND CONTACT YOUR DOCTOR
  1. 5. Genital warts can come back. If your warts come back, contact your doctor.

SPECIAL CAUTIONS

  • Genital warts are contagious. You can give them to or get them from your sexual partner. Make sure your sexual partner has been checked for genital warts. Condoms can help protect both you and your partner. Do not have sexual intercourse for the three days you are applying Podofilox Topical Solution.
  • Women should make sure to use birth control so they will not get pregnant while on Podofilox Topical Solution. The effects on the unborn baby are not known. Women can use Podofilox Topical Solution during their menstrual period.
  • Podofilox Topical Solution is prescribed only for your external genital warts. Do not let anyone else use it.

REMEMBER:

  • Do not use the applicator more than once. Throw it away so it can not infect anyone else.
  • Always wash your hands after using Podofilox Topical Solution.
  • Do not get it in your eyes. If you do, immediately flush your eyes with water and contact your doctor.
  • Keep the bottle tightly closed and store in an upright position.
  • Be sure to keep this and all medications out of the reach of children.

CONTACT YOUR DOCTOR IF YOU HAVE QUESTIONS ABOUT PODOFILOX TOPICAL SOLUTION

Manufactured by Padagis

Minneapolis, MN 55427

www.padagis.com

2204593

4U300 RC PA1

Rev 02-23

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 075600 · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Podofilox

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredient Podofilox 5 mg/mL
Dosage form Solution
Route Topical
Marketing status listed in the FDA NDC Directory
Company (applicant) PADAGIS US
FDA approval ANDA 075600Abbreviated New Drug Application (ANDA) – generic drug Approved January 29, 2002
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
5 mg/mL – 3.5 ml in 1 bottle, glass / 1 in 1 carton NDC 0574-0611-05

Source: FDA drug labeling via NLM DailyMed, data as of November 3, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.